Melissa Sherman
banner
mobilionceo.bsky.social
Melissa Sherman
@mobilionceo.bsky.social
CEO of MOBILion Systems Inc....Advancing separation science to Reveal What Others Leave Unseen
Become a BILLIEver ....this is what our future BILLIE platform achieves, continuing to reveal what others leave unseen:

🔬 Glycan site specificity, which translates to
🚀 Better vaccine efficacy

BILLIEve it.
When it comes to evaluating immunogenicity, it’s not just what glycans are there—it’s where. At #ASMS2025, Yates Lab used PAMAF on SLIM-HRIM to deeply map SARS-CoV-2 spike glycosylation, achieving >80% seq. coverage without a library. #proteomics #glyco go.mobilionsystems.com/BILLIEverVIP
July 17, 2025 at 2:57 PM
Reposted by Melissa Sherman
Is Mass Spec-based proteomics dead, dying… or a dark horse?
Bringing mass spectrometry to clinical use is the key to its future. We have been featured in @GENbio exploring this question – access the article here: www.genengnews.com/topics/omics...

#Proteomics #BILLIE #PAMAF #Biotech
July 8, 2025 at 12:30 PM
Reposted by Melissa Sherman
What if your PFAS analysis is missing critical compounds?
Our new app note shows how the @EPA used the MOBIE system’s high-res separations to reveal hidden #PFAS isomers that conventional methods miss.

Learn more: www.mobilionsystems.com/resources/ig...
February 28, 2025 at 8:05 PM
Reposted by Melissa Sherman
How many soft spots are you missing?

Read how Merck achieved 72% faster analysis times and 200% higher resolving power using the MOBIE system for cyclic peptide characterization, supporting more precise drug development decisions.

www.mobilionsystems.com/resources/me...
March 18, 2025 at 2:37 PM